Nurix Therapeutics Announces Addition of Dr. Jason Kantor to its Management Team
13 juil. 2020 08h00 HE
|
Nurix
SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced the appointment of Dr. Jason Kantor as senior vice...
Nurix Therapeutics Announces Addition of Immuno-Oncology Clinical Experts to its Management Team
16 juin 2020 08h00 HE
|
Nurix
SAN FRANCISCO, June 16, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced the appointment of Dr. Michael T. Lotze as chief...
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
12 mars 2020 08h00 HE
|
Nurix
SAN FRANCISCO, March 12, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced it has closed an oversubscribed $120 million...
Nurix Therapeutics to Present at the Cowen & Co. 40th Annual Health Care Conference
27 févr. 2020 08h00 HE
|
Nurix
SAN FRANCISCO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs, today announced that CEO Arthur Sands will present at the Cowen...
Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies
09 janv. 2020 08h00 HE
|
Nurix
SAN FRANCISCO, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company researching novel therapies that control degradation of disease-causing proteins, today announced a global...
Nurix Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
08 janv. 2020 08h00 HE
|
Nurix
SAN FRANCISCO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing targeted protein modulation drugs announced today that CEO Arthur Sands will present at the 38th...
Nurix Therapeutics Announces Scientific Presentations on its BTK Program at the 61st American Society of Hematology Annual Meeting
18 nov. 2019 08h00 HE
|
Nurix
SAN FRANCISCO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing novel therapies that control disease-causing proteins, today announced an oral presentation on its...
Nurix Therapeutics Announces Key Management Additions
14 nov. 2019 08h00 HE
|
Nurix
SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced the appointment of Dr. Christine Ring...
Nurix Therapeutics Announces Upcoming Investor Conference Schedule
12 nov. 2019 08h00 HE
|
Nurix
SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that the Company management team will...
Nurix Therapeutics Announces Upcoming Scientific Presentation for its CBL-B Program at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)
22 oct. 2019 08h00 HE
|
Nurix
SAN FRANCISCO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc., a company developing therapies that control disease-causing proteins, today announced that it will present data on its...